График акции Indaptus Therapeutics, Inc.
Расширенный график
Простой график
О компании Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. подробнее| IPO date | 2015-08-04 |
|---|---|
| ISIN | US45339J1051 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://indaptusrx.com |
| Цена ао | 0.8174 |
| Изменение цены за день: | +6.78% (0.7857) |
|---|---|
| Изменение цены за неделю: | +4.87% (0.8) |
| Изменение цены за месяц: | -8.8% (0.92) |
| Изменение цены за 3 месяца: | -17.75% (1.02) |
| Изменение цены за полгода: | -46.56% (1.5699) |
| Изменение цены за год: | -59.86% (2.09) |
| Изменение цены за 3 года: | -80.84% (4.38) |
| Изменение цены за 5 лет: | +188.61% (0.2907) |
| Изменение цены за 10 лет: | 0% (0.839) |
| Изменение цены с начала года: | +0.3709% (0.8359) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Vanguard Group Inc | 256265 | 3 |
| Investment House, LLC | 102437 | 1.2 |
| Geode Capital Management, LLC | 54767 | 0.64 |
| Strategy Asset Managers Llc | 45336 | 0.53 |
| Pine Valley Investments Ltd Liability Co | 44240 | 0.52 |
| Renaissance Technologies, LLC | 29400 | 0.34 |
| Vivaldi Capital Management Lp | 24000 | 0.28 |
| State Street Corporation | 19473 | 0.23 |
| Citadel Advisors Llc | 16518 | 0.19 |
| Tower Research Capital LLC (TRC) | 4696 | 0.05 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Mr. Jeffrey A. Meckler | CEO & Director | 867.03k | 1967 (58 лет) |
| Mr. Walt Addison Linscott Esq. | Chief Operating Officer | 716.35k | 1961 (64 года) |
| Dr. Michael J. Newman Ph.D. | Founder, Chief Scientific Officer & Director | 659.99k | 1956 (69 лет) |
| Mr. Nir Sassi | CFO, Secretary & Treasurer | 378.47k | 1976 (49 лет) |
| Dr. Roger J. Waltzman M.B.A., M.D. | Chief Medical Officer | N/A | 1968 (57 лет) |
Адрес: United States, New York. NY, Three Columbus Circle - открыть в Google картах, открыть Яндекс картах
Сайт: https://indaptusrx.com
Сайт: https://indaptusrx.com
